Nexplanon is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Etonogestrel.
| Product ID | 78206-145_2b6805f7-1ff5-40bf-a028-a173a7fdb580 |
| NDC | 78206-145 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nexplanon |
| Generic Name | Etonogestrel |
| Dosage Form | Implant |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | NDA / |
| Application Number | NDA021529 |
| Labeler Name | Organon LLC |
| Substance Name | ETONOGESTREL |
| Active Ingredient Strength | 68 mg/1 |
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0052-4330 | Nexplanon | etonogestrel |
| 78206-145 | Nexplanon | etonogestrel |
| 0052-0272 | IMPLANON | etonogestrel |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NEXPLANON 79028211 3362650 Live/Registered |
MERCK SHARP & DOHME B.V. 2006-05-04 |